- Home
- PBFS vs VOR Comparison
PBFS vs VOR Comparison
Compare PBFS & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBFS
- VOR
- Stock Information
- Founded
- PBFS 1889
- VOR 2015
- Country
- PBFS United States
- VOR United States
- Employees
- PBFS N/A
- VOR N/A
- Industry
- PBFS Banks
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- PBFS Finance
- VOR Health Care
- Exchange
- PBFS Nasdaq
- VOR Nasdaq
- Market Cap
- PBFS 311.6M
- VOR 261.0M
- IPO Year
- PBFS N/A
- VOR 2021
- Fundamental
- Price
- PBFS $13.35
- VOR $1.74
- Analyst Decision
- PBFS
- VOR Buy
- Analyst Count
- PBFS 0
- VOR 6
- Target Price
- PBFS N/A
- VOR $3.90
- AVG Volume (30 Days)
- PBFS 21.4K
- VOR 4.2M
- Earning Date
- PBFS 11-11-2025
- VOR 11-06-2025
- Dividend Yield
- PBFS N/A
- VOR N/A
- EPS Growth
- PBFS 50.26
- VOR N/A
- EPS
- PBFS 0.91
- VOR N/A
- Revenue
- PBFS $91,369,000.00
- VOR N/A
- Revenue This Year
- PBFS N/A
- VOR N/A
- Revenue Next Year
- PBFS N/A
- VOR N/A
- P/E Ratio
- PBFS $14.67
- VOR N/A
- Revenue Growth
- PBFS 23.15
- VOR N/A
- 52 Week Low
- PBFS $10.60
- VOR $0.13
- 52 Week High
- PBFS $13.44
- VOR $3.29
- Technical
- Relative Strength Index (RSI)
- PBFS 63.09
- VOR 39.03
- Support Level
- PBFS $13.14
- VOR $1.80
- Resistance Level
- PBFS $13.26
- VOR $2.03
- Average True Range (ATR)
- PBFS 0.22
- VOR 0.15
- MACD
- PBFS 0.02
- VOR -0.04
- Stochastic Oscillator
- PBFS 87.32
- VOR 1.28
About PBFS Pioneer Bancorp Inc.
Pioneer Bancorp Inc is involved in providing banking services. These services include Personal services such as Checking, Savings, eBanking Cards, and Business services such as Business Deposit and operating Accounts, Business eBanking, and Business loans. Some of the other services of the company include Government Banking, Wealth Management, Benefits Consulting and Insurance.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.